Day: February 23, 2023

Redox potential tuning in bio-relevant heterocycles via (anti)aromaticity modulated H-bonding (AMHB) was written by Kakeshpour, Tayeb;Van Wiemeersch, Adam;Jackson, James E.. And the article was included in Canadian Journal of Chemistry in 2020.Application In Synthesis of 1-Hydroxyisoquinoline This article mentions the following:

Hydrogen bonds are arguably the most important non-covalent interactions in chem. and biol., and their strength and directionality have been elegantly exploited in the rational design of complex structures. We recently noted that the variable responses of cyclic 蟺-systems upon H-bond formation reciprocally lead to modulations of the H-bonds鈥?strengths, a phenomenon that we dubbed (anti)aromaticity-modulated hydrogen bonding (AMHB) [J. Am. Chem. Soc.2016, 138, 3427-3432]. Species that switch from aromatic to antiarom. or vice versa upon changing 蟺-electron counts should be oppositely stabilized by the AMHB effects, so their redox potentials should be significantly “tuned” by H-bond formation. Herein, using quantum chem. simulations, we explore the effects of these H-bond induced 蟺-electron polarizations on the redox potentials of (anti)aromatic heterocycles. The systems chosen for this study have embedded amide groups and amidine moieties capable of forming two-point H-bonds in their cyclic 蟺-systems. Thus, as the 4-electron and 6-electron 蟺-systems in redox-capable monocycles (e.g., quinones) can be differentially stabilized, their redox potentials can be modulated by H-bond formation by as much as 6 kcal/mol (258 mV for one electron transfer). In fused rings, the connectivity patterns are as important as the 蟺-electron counts. Extending these ideas to flavin, a biol. relevant case, we find that H-bonding patterns like those found in its crystals can vary its redox potential by up to 1.3 kcal/mol. In the experiment, the researchers used many compounds, for example, 1-Hydroxyisoquinoline (cas: 491-30-5Application In Synthesis of 1-Hydroxyisoquinoline).

1-Hydroxyisoquinoline (cas: 491-30-5) belongs to isoquinoline derivatives. Isoquinoline is a structural isomer of quinoline, which have antiseptic, antipyretic and anti-cyclic properties, and can be used as antimalarial drugs and for the preparation of other antimalarial medicine. They are also used to make oil-soluble dyes, food colorants, pharmaceuticals, pH indicators and other organic compounds. Application In Synthesis of 1-Hydroxyisoquinoline

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Iridium-catalyzed asymmetric hydrogenation of cyclic iminium salts was written by Ji, Yue;Feng, Guang-Shou;Chen, Mu-Wang;Shi, Lei;Du, Haifeng;Zhou, Yong-Gui. And the article was included in Organic Chemistry Frontiers in 2017.Application of 52250-50-7 This article mentions the following:

An enantioselective hydrogenation of cyclic iminium salts has been successfully realized by employing [Ir(COD)Cl]₂ and chiral diphosphine ligands as catalyst, furnishing chiral N-alkyl tetrahydroisoquinolines and N-alkyl tetrahydro-尾-carbolines with up to 96% ee and 88% ee, resp. The hydrogenation provides a direct, simple and efficient protocol toward chiral tertiary amines. Meanwhile, asym. hydrogenation at the gram scale was also conducted smoothly without loss of reactivity and enantioselectivity. In the experiment, the researchers used many compounds, for example, 1-Phenyl-3,4-dihydroisoquinoline (cas: 52250-50-7Application of 52250-50-7).

1-Phenyl-3,4-dihydroisoquinoline (cas: 52250-50-7) belongs to isoquinoline derivatives. Being an analog of pyridine, isoquinoline is a weak base, with a pKa of 5.14. Isoquinoline-type alkaloids show biological activities similar to those of morphinane-, protoberberine-, and benzophenanthridine-type alkaloids.Application of 52250-50-7

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Protective effects of the ROCK inhibitor fasudil against cognitive dysfunction following status epilepticus in male rats was written by Song, Xiaojie;He, Rong;Han, Wei;Li, Tianyi;Xie, Lingling;Cheng, Li;Chen, Hengsheng;Xie, Mingdan;Jiang, Li. And the article was included in Journal of Neuroscience Research in 2019.Computed Properties of C14H18ClN3O2S This article mentions the following:

Despite remarkable advances in epilepsy research, prevention and reversal of cognitive deficits following epilepsy remain a challenge. It was reported that the Rho kinase (ROCK) inhibitor fasudil hydrochloride (FH) could improve cognitive deficits in animal models of Alzheimer’s disease (AD). Thus, the aim of the present study was to determine whether FH-mediated inhibition of the effects of ROCK signaling could improve cognitive deficits in male rats (postnatal 21-day old) following status epilepticus (SE) induced by lithium-pilocarpin, the therapeutic window of opportunity and to elucidate the underlying mechanisms. Western blotting anal. showed upregulation of phosphorylated RhoA (p-RhoA) expression, and indicated activation of Rho/ROCK signaling after SE. The Morris water maze (MWM) test was used to analyze learning-memory ability. HE staining, immunofluorescence staining with antineuronal nuclei (NeuN) and anti-neurofilament proteins 200 kD (NF200), transmission electron microscopy, and quant. anal. of NeuN and synaptophysin by western blotting were performed to observe alterations in neurons, axons, and synapses in the hippocampi. EEG (EEG) monitoring was used to record electrophysiol. activities after SE. Our results indicated that treatment with FH at the first day following SE or 5 days later both could ameliorate cognitive dysfunction by reducing neuron, axon, and synapse damage, and mitigating EEG discharges, suggesting various roles for the Rho/ROCK signaling pathway in the pathol. processes of brain damages following SE induced by lithium-pilocarpine. The Rho/ROCK signaling pathway is, therefore, a potential therapeutic target for the prevention or reversal of epilepsy induced brain damages. In the experiment, the researchers used many compounds, for example, 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride (cas: 105628-07-7Computed Properties of C14H18ClN3O2S).

5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride (cas: 105628-07-7) belongs to isoquinoline derivatives. Being an analog of pyridine, isoquinoline is a weak base, with a pKa of 5.14. It protonates to form salts upon treatment with strong acids, such as HCl. It forms adducts with Lewis acids, such as BF3.Computed Properties of C14H18ClN3O2S

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity was written by Tannenbaum, Stacey;den Adel, Martin;Krauwinkel, Walter;Meijer, John;Hollestein-Havelaar, Adriana;Verheggen, Frank;Newgreen, Donald. And the article was included in Pharmacology Research & Perspectives in 2020.Recommanded Product: (S)-(R)-Quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate This article mentions the following:

The aim of this investigation was to characterize and compare the pharmacokinetics (PK) of the antimuscarinic drug solifenacin in pediatric patients with overactive bladder (OAB) or neurogenic detrusor overactivity (NDO) utilizing data from three phase III trials. LION was a placebo-controlled, 12-wk trial in children (5-<12 years) and adolescents (12-<18 years) with OAB. MONKEY and MARMOSET were open-label, 52-wk trials in children and adolescents or younger children (6 mo-<5 years), resp., with NDO. During the trials, solifenacin doses could be titrated to weight-adjusted pediatric equivalent doses (PEDs) of 2.5, 5, 7.5, or 10 mg day^-1. Nonlinear mixed effects modeling was used to develop population PK models to characterize the PK in patients with either OAB or NDO. Overall, 194 children and adolescents received solifenacin. At the time of PK sampling, the majority (119/164 [72.6%] patients) were receiving PED10 once daily. All population models included first-order oral absorption, a lag time, and interindividual variability. PK anal. showed that apparent clearance was similar in both patient populations. Mean apparent oral plasma clearance (CL/F), apparent volume of distribution during the terminal phase (V_z/F), and terminal half-life (t_1/2) were higher in adolescents than in children, but median time to maximum plasma concentration (t_max) was similar. Dose-normalized exposure results were similar for both younger and older patients with OAB or NDO. In conclusion, population PK modeling was used to successfully characterize solifenacin PK in pediatric patients with OAB or NDO. Similar solifenacin PK characteristics were observed in both populations. In the experiment, the researchers used many compounds, for example, (S)-(R)-Quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate (cas: 242478-37-1Recommanded Product: (S)-(R)-Quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate).

(S)-(R)-Quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate (cas: 242478-37-1) belongs to isoquinoline derivatives. Quinoline and its derivatives are widely used as fungicides, biological agents, antibiotics, alkaloids, dyes, rubber chemicals and flavoring agents. The discovery of chloroquine, the most well-known drug containing this stent, has helped bring about decades of malaria control and treatment.Recommanded Product: (S)-(R)-Quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Polyphosphate esters as synthetic agents. II. Bischler-Napieralski reaction by means of polyphosphate esters and synthesis of 5H-2-benzazepine derivatives was written by Kanaoka, Yuichi;Sato, Eisuke;Yonemitsu, Osamu;Ban, Yoshio. And the article was included in Tetrahedron Letters in 1964.Reference of 52250-50-7 This article mentions the following:

Polyphosphate ester (I, prepared from P₂O₅ and Et₂O in CHCl₃ and used in situ, 5 parts) refluxed with 3,4-R₂C₆H₂CH₂CH₂NHCOR’ (R = MeO, R’ = Me; R = MeO, R’ = Ph; R = H,R’ = Me; R = H, R’ = Ph) 0.5-1.5 h. yielded 78-89% of the corresponding dihydroisoquinolines. Similarly, 3,4-(MeO)₂C₆H₃(CH₂)₃NHCOR (R = H, Me, Ph) were cyclized to yield the corresponding benzazepines (II, R = H, Me, Ph) (III, IV, V), in 76, 63, and 93% (crude) yields, resp., reduced by NaBH₄ to the resp. dihydro compounds (VII, VIII, IX). Phys. data are tabulated (compound, m.ps. of base, picrate, perchlorate, and methiodide given): III, 165-6掳, 197-8掳, 234掳 (decomposition), 182-5掳; IV, 140-3掳, 183-4掳, 190-1掳, 190-1掳; V, -, 222掳 (decomposition), 246-7掳 (decomposition), 206-6.5掳 (decomposition); VII, 172-3掳, 197-8, -, -; VIII, 115-20掳 (b. 3掳), 163-5, -, -; IX, 114-15, -, -, -. In the experiment, the researchers used many compounds, for example, 1-Phenyl-3,4-dihydroisoquinoline (cas: 52250-50-7Reference of 52250-50-7).

1-Phenyl-3,4-dihydroisoquinoline (cas: 52250-50-7) belongs to isoquinoline derivatives. Being an analog of pyridine, isoquinoline is a weak base, with a pKa of 5.14. Lewis acid activation and nucleophilic attack can produce multiple regioisomers in quinolines and pyridines; isoquinolines generally only undergo attack at the 1-position.Reference of 52250-50-7

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Effect of hydrochloride fasudil on IL-1尾, TNF-伪 and RHO kinase in serum of patients with cerebral infarction was written by Li, Tong;Tian, Hong-ying;Deng, Yan;Su, Da-jing;He, Ning-yu. And the article was included in Hainan Yixueyuan Xuebao in 2011.Name: 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride This article mentions the following:

Objective: To explore effect of hydrochloride fasudil on IL-1尾, TNF-伪 and RHO kinase in serum of patients with cerebral infarction. Methods: A total of 186 cases with cerebral infarction were divided into two groups. Patients in observation group were treated by routine therapy and hydrochloride fasudil; while patients in control group were treated by routine therapy. Expressions of IL-1尾, TNF-伪 and RHO kinase were detected before and after treatment. The efficacy and changes of IL-1尾, TNF-伪 and RHO kinase in serum were observed and compared. Results: The efficacy was higher in the observation group than in the control group. The expressions of IL-1尾, TNF-伪 and RHO kinase were significantly decreased after treatment. But the decrease of IL-1尾, TNF-伪 and RHO kinase was more significant in the observation group than in the control group. Conclusions: Hydrochloride fasudil can improve the efficacy, inhibit the expressions of IL-1尾, TNF-伪 and RHO kinase, and protect the cerebral cells in patients with cerebral infarction. In the experiment, the researchers used many compounds, for example, 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride (cas: 105628-07-7Name: 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride).

5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride (cas: 105628-07-7) belongs to isoquinoline derivatives. Quinoline is a catabolite of tryptophan, the basic structure of some antihypertensive drugs, such as the peripheral vasodilators prazosin and doxazosin. The discovery of chloroquine, the most well-known drug containing this stent, has helped bring about decades of malaria control and treatment.Name: 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

An extended 蟺-system and enhanced electronic delocalization on symmetric [Ru₃O(CH₃COO)₆(L)₃]ⁿ complexes combined with azanaphthalene ligands was written by Possato, Bruna;Deflon, Victor M.;Naal, Zeki;Formiga, Andre L. B.;Nikolaou, Sofia. And the article was included in Dalton Transactions in 2017.Computed Properties of C9H6N2O2 This article mentions the following:

The authors report on the study of sym. trinuclear Ru complexes combined with azanaphthalene ligands: [Ru₃O(CH₃COO)₆(L)₃]PF₆ where L = (1) quinazoline (qui), (2) 5-nitroisoquinoline (5-nitroiq), (3) 5-bromoisoquinoline (5-briq), (4) isoquinoline (iq), (5) 5-aminoisoquinoline (5-amiq), and (6) 5,6,7,8-tetrahydroisoquinoline (thiq). The crystal structure of complex 1, [Ru₃O(CH₃COO)₆(qui)₃]PF₆, was determined by x-ray diffraction anal., showing a high degree of coplanarity between the [Ru₃O] plane and the azanaphthalene ligands. Spectroscopic (UV-visible, NMR and IR) and electrochem. (cyclic voltammetry and spectroelectrochem.) data showed correlation with the pK_a values of the azanaphthalene ligands and this dependence was rationalized in terms of the MO of the [Ru₃O] unit and the structure of the ligands. By analyzing the spectroscopic and electrochem. correlations, the ability of the azanaphthalene ligands to extend the electronic 蟺-system of the [Ru₃O] unit to the periphery of the compounds was demonstrated. This electronic effect accounts for the planarity of the structure of 1. It was also shown through mol. modeling results that, to explain the spectroscopic and electrochem. behavior of these species, it is not possible to neglect the electronic mixing between the metallic and the acetate orbitals. This work also revealed that electronic coupling is more pronounced in the azanaphthalene complex series than in pyridinic analogs and it is this coupling that determines the spectroscopic and electrochem. behavior of the new species. In the experiment, the researchers used many compounds, for example, 5-Nitroisoquinoline (cas: 607-32-9Computed Properties of C9H6N2O2).

5-Nitroisoquinoline (cas: 607-32-9) belongs to isoquinoline derivatives. Isoquinoline is a structural isomer of quinoline, which have antiseptic, antipyretic and anti-cyclic properties, and can be used as antimalarial drugs and for the preparation of other antimalarial medicine. Most traditional methods of generating isoquinoline do so via oxidative aromatization of dihydro- or tetrahydro-isoquinolines, usually offering some environmental or economic advantage.Computed Properties of C9H6N2O2

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment was written by Gratzke, Christian;Chapple, Christopher;Mueller, Elizabeth R.;Robinson, Dudley;Rolland, Catherine;Staskin, David;Stoelzel, Matthias;Maanen, Rob van;Siddiqui, Emad. And the article was included in European Urology in 2019.Related Products of 242478-37-1 This article mentions the following:

Studies reporting the efficacy/safety of two antimuscarinics or a 尾3-adrenoreceptor agonist plus an antimuscarinic were included.Publications reported on clin. efficacy, safety, and health-related quality of life (HRQoL) for mirabegron (M) plus solifenacin (S) from three 12-wk randomised controlled trials (RCTs)-SYMPHONY, SYNERGY, and BESIDE-and a 12-mo RCT, SYNERGY II. SYMPHONY reported statistically significant improvements in clin. symptoms and HRQoL with combination therapy vs. solifenacin 5 mg (S5) and placebo. In SYNERGY II, clin. meaningful and sustained improvements in clin. outcomes were observed for M50 + S5 vs. M50 or S5. Combination therapy was well tolerated in all four trials. The incidence of adverse events (AEs) was similar across groups, and there were no notable differences in the incidence of specific AEs. Pos. efficacy outcomes were observed in five studies of dual antimuscarinic therapy (trospium + solifenacin).Mirabegron plus solifenacin provides effective, well-tolerated treatment for patients with OAB. We looked at published scientific studies of patients with OAB treated with mirabegron plus solifenacin together, or with two antimuscarinics. We found that mirabegron plus solifenacin can help reduce symptoms and improve quality of life. Patients tolerate this treatment well, with few patients experiencing side effects. In the experiment, the researchers used many compounds, for example, (S)-(R)-Quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate (cas: 242478-37-1Related Products of 242478-37-1).

(S)-(R)-Quinuclidin-3-yl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate (cas: 242478-37-1) belongs to isoquinoline derivatives. Quinoline and its derivatives are widely used as fungicides, biological agents, antibiotics, alkaloids, dyes, rubber chemicals and flavoring agents. The Pomeranz鈥揊ritsch reaction provides a method for the preparation of isoquinoline. This reaction uses a benzaldehyde and aminoacetoaldehyde diethyl acetal, which in an acid medium react to form isoquinoline.Related Products of 242478-37-1

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

Design, synthesis and biological evaluations of a long-acting, hypoxia-activated prodrug of fasudil, a ROCK inhibitor, to reduce its systemic side-effects was written by Al-Hilal, Taslim A.;Hossain, Mohammad Anwar;Alobaida, Ahmad;Alam, Farzana;Keshavarz, Ali;Nozik-Grayck, Eva;Stenmark, Kurt R.;German, Nadezhda A.;Ahsan, Fakhrul. And the article was included in Journal of Controlled Release in 2021.Electric Literature of C14H18ClN3O2S This article mentions the following:

ROCK, one of the downstream regulators of Rho, controls actomyosin cytoskeleton organization, stress fiber formation, smooth muscle contraction, and cell migration. ROCK plays an important role in the pathologies of cerebral and coronary vasospasm, hypertension, cancer, and arteriosclerosis. Pharmacol.-induced systemic inhibition of ROCK affects both the pathol. and physiol. functions of Rho-kinase, resulting in hypotension, increased heart rate, decreased lymphocyte count, and eventually cardiovascular collapse. To overcome the adverse effects of systemic ROCK inhibition, we developed a bioreductive prodrug of a ROCK inhibitor, fasudil, that functions selectively under hypoxic conditions. By masking fasudil鈥瞫 active site with a bioreductive 4-nitrobenzyl group, we synthesized a prodrug of fasudil that is inactive in normoxia. Reduction of the protecting group initiated by hypoxia reveals an electron-donating substituent that leads to fragmentation of the parent mol. Under normoxia the fasudil prodrug displayed significantly reduced activity against ROCK compared to its parent compound, but under severe hypoxia the prodrug was highly effective in suppressing ROCK activity. Under hypoxia the prodrug elicited an antiproliferative effect on disease-afflicted pulmonary arterial smooth muscle cells and pulmonary arterial endothelial cells. The prodrug displayed a long plasma half-life, remained inactive in the blood, and produced no drop in systemic blood pressure when compared with fasudil-treated controls. Due to its selective nature, our hypoxia-activated fasudil prodrug could be used to treat diseases where tissue-hypoxia or hypoxic cells are the pathol. basis of the disease. In the experiment, the researchers used many compounds, for example, 5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride (cas: 105628-07-7Electric Literature of C14H18ClN3O2S).

5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride (cas: 105628-07-7) belongs to isoquinoline derivatives. Although isoquinoline derivatives can be synthesized by several methods, relatively few direct methods deliver the unsubstituted isoquinoline. The Pomeranz鈥揊ritsch reaction provides a method for the preparation of isoquinoline. This reaction uses a benzaldehyde and aminoacetoaldehyde diethyl acetal, which in an acid medium react to form isoquinoline.Electric Literature of C14H18ClN3O2S

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

The role of the aromatic ligand in the asymmetric transfer hydrogenation of the C=N bond on Noyori’s chiral Ru catalysts was written by Sot, Petr;Vilhanova, Beata;Pechacek, Jan;Vaclavik, Jiri;Zapal, Jakub;Kuzma, Marek;Kacer, Petr. And the article was included in Tetrahedron: Asymmetry in 2014.Application of 52250-50-7 This article mentions the following:

Only four types of dimeric precursors [RuCl₂(畏⁶-arene)]₂ for the synthesis of Noyori’s half sandwich diamine catalysts [RuCl(TsDPEN)(畏⁶-arene)] are com. available, yet so far no study has tried to systematically evaluate how these systems perform during an asym. transfer hydrogenation of various 3,4-dihydroisoquinolines (i.e., the typical substrates for Noyori asym. transfer hydrogenation benchmarks). Experiments combined with mol. modeling allowed us to assess their properties and formulate a hypothesis clarifying the difference in enantioselectivity of these systems. The synthesis of the target compounds was achieved using [N-[(1S,2S)-2-(amino-魏N)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-魏N](畏⁶-benzene)(chloro)ruthenium and related catalysts, [N-[(1S,2S)-2-(amino-魏N)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-魏N]chloro[(1,2,3,4,5,6-畏)-1,3,5-trimethylbenzene]ruthenium, [N-[(1S,2S)-2-(amino-魏N)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-魏N]chloro[(1,2,3,4,5,6-畏)-1-methyl-4-(1-methylethyl)benzene]ruthenium and [N-[(1S,2S)-2-(amino-魏N)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-魏N]chloro[(1,2,3,4,5,6-畏)-1,2,3,4,5,6-hexamethylbenzene]ruthenium. Starting materials included 3,4-dihydro-6,7-dimethoxy-1-(methyl)isoquinoline, 3,4-dihydro-1-(phenyl)isoquinoline. The enantiomeric excess of products was determined after derivatization with carbonochloridic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester [(-)-menthyl chloroformate]. The title compounds thus formed included 3,4-dihydro-2(1H)-isoquinolinecarboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester derivatives In the experiment, the researchers used many compounds, for example, 1-Phenyl-3,4-dihydroisoquinoline (cas: 52250-50-7Application of 52250-50-7).

1-Phenyl-3,4-dihydroisoquinoline (cas: 52250-50-7) belongs to isoquinoline derivatives. Quinoline is a mancude organic heterobicyclic parent, an azaarene, an ortho-fused heteroarene and a member of isoquinolines. Isoquinoline-type alkaloids show biological activities similar to those of morphinane-, protoberberine-, and benzophenanthridine-type alkaloids.Application of 52250-50-7

Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem